There is a possibility of the heparin line is occluded.
Source facts
Action
Customers were notified on approximately December 19, 2017, via letter. Instructions included to place affected lots on hold and to advise Nipro if any affected product has been further distributed. If affected product has been further distributed, Nipro advised the customer to notify those customers and have the product returned immediately. Additionally Nipro requested that they complete and return the response form to arrange for product return. For further questions, please call (305) 599-7174.
Initiated
2017-12-19
Root cause
Process control
Terminated
2021-10-19
Distribution
US Distribution to the states of : GA, NY, TN, TX.
Recall number
Z-1876-2018
Recall status
Terminated
CDRH record ID
163665
FDA record created
2018-05-15
Recall event number
79834
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.